Tiotropium In Exercise

• Status: Completed
• Trial end date: 1969-12-31

Summary

The objective of this study is to evaluate the effects on exercise duration of 96 weeks treatment with 18 mcg tiotropium (Spiriva HandiHaler) daily as compared to placebo, in patients with COPD.

• Phase: Phase 4

Details

• Lead Sponsor: Boehringer Ingelheim
• Collaborator: Pfizer
• Treatments: Tiotropium Bromide